An A549 NSCLC cell derived cisplatin resistant cell line A549/DR exhibits upregulation of multiple FA genes and elevated FANCD2 monoubiquitination compared to its parental and other NSCLC lines [107]. Here, FANCD2 is linked to non-small cell lung carcinoma.